Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HTL0018318 in dementia with Lewy bodies
jRCT2080223932Phase 2Terminated
- Sponsor
- Nxera Pharma
- Start
- Jun 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of HTL0018318 in dementia with Lewy bodies (DLB) (4 arms), sponsored by Nxera Pharma. Started Jun 2018; status: terminated.
02
Drugs
HTL0018318
03
Conditions
dementia with Lewy bodies (DLB)
Beyond the preview
Go deeper on jRCT2080223932.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223932.